Skip to main content
. 2023 Oct 11;18(10):e0292678. doi: 10.1371/journal.pone.0292678

Fig 7. Prognosis in TCGA BRCA patients with HER2– tumors.

Fig 7

Survival for (A) premenopausal and (B) postmenopausal patients was observed with low (< 10.43 FPKM for premenopausal and < 10.37 FPKM for postmenopausal) and high (> = 10.43 FPKM for premenopausal and > = 10.37 FPKM for postmenopausal) LAT1 expression.